IQVIA Holdings Inc. (IQV) Stock

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

IQVIA Holdings Inc. is led by CEO Ari Bousbib, employs 89,000 people, headquartered in Durham, US, publicly traded since 2013.

IQVIA Holdings Inc. (IQV) stock trades at $235.00 with a market capitalization of $39.22B. The stock is valued at a price-to-earnings (P/E) ratio of 22.17, price-to-book of 4.66, price-to-sales of 1.66. Over the past 52 weeks the stock has ranged between $153.01 and $247.05, and currently trades 4.9% below its 52-week high.

On profitability, IQVIA Holdings Inc. generates a return on equity (ROE) of 22.49% — well above the market average, a sign of a high-quality business, return on capital employed of 34.49%, an operating margin of 14.02%, a net profit margin of 8.33%.

In its most recent fiscal year, IQVIA Holdings Inc. reported annual revenue of $16.3B, net profit of $1.4B, revenue has compounded at 7.5% a year over the last five years, profit at 37.3% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.33 — a conservative balance sheet with little leverage risk, a current ratio of 0.75, total assets of $29.9B, $2.0B in cash and equivalents.

IQV has an average daily trading volume of 1,600,000 shares, a beta of 1.22.

Official website: www.iqvia.com